LEVOBUPIVACAINE KABI 1.25 mg/ml, solution for infusion 5 bags of 100 ml
Active ingredients: Levobupivacaine hydrochloride, Levobupivacaine
Commercialized according to BDPMDispensing in France: Prescription only, hospital use
Solution for infusion5 bags of 100 mlpéridurale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- LEVOBUPIVACAINE KABI 1,25 mg/ml, solution pour perfusion
- Pharmaceutical form
- solution pour perfusion
- Route of administration
- péridurale
- Presentation description
- 5 poche(s) polyoléfine suremballée(s)/surpochée(s) de 100 ml
- Marketing authorisation holder
- FRESENIUS KABI FRANCE
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 23 Nov 2015
- Prescription and dispensing conditions
- Prescription only, hospital use
- List I: prescription-only medicine
- Hospital use only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
62150722CIP75869263CIP133400958692635Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| CHLORHYDRATE DE LÉVOBUPIVACAÏNEsolution | — | SA |
| LÉVOBUPIVACAÏNEsolution | 1,25 mg · 1 ml de solution | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.